For citations:
Moskaleva P.V., Shnayder N.A., Neznanov N.G., Dmitrenko D.V., Golokov V.A., Nasyrova R.F. Exogenous melatonin as a disease-modifying therapy for epilepsy. Epilepsy and paroxysmal conditions. 2019;11(2):124-141. (In Russ.) https://doi.org/10.17749/2077-8333.2019.11.2.124-141
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
